Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1360-1367

  Knepper, Paul A ^a,c   Goossens, William ^a   Hvizd, Michael ^a   Palmberg, Paul F ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

aqueous outflow resistance; chondroitin sulfate; glaucoma; glycosaminoglycans; hyaluronic acid; trabecular meshwork

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; KERATAN SULFATE;

AGED; ARTICLE; CILIARY BODY; DENSITOMETRY; HUMAN; HUMAN TISSUE; IRIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SCLERA; TRABECULAR MESHWORK;

AGED; AGED, 80 AND OVER; CILIARY BODY; ELECTROPHORESIS, CELLULOSE ACETATE; FEMALE; GLAUCOMA, OPEN-ANGLE; GLYCOSAMINOGLYCANS; HUMANS; IRIS; MALE; SCLERA; TRABECULAR MESHWORK;

EID: 0029951066     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Acott TS, Westcott M, Passo MS, Van Buskirk EM. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eyes. Invest Ophthalmol Vis Sci. 1985;26:1320-1329.
2. Knepper PA, McLone DG. Glycosaminoglycans and outflow pathways of the eye and brain. Pediatr Neurosci. 1986;12:240-251.
3. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978; 58:255-315.
4. Scott JE. Secondary structures in hyaluronan solutions: Chemical and biological implications. In: Evered D, Whelan J, eds. The Biology of Hyaluronan. Chichester: John Wiley & Sons; 1989:6-20.
5. Lin CQ, Bissell MJ. Multifaceted regulation of differentiation by extracellular matrix. FASEB J. 1993; 7:737-743.
6. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
7. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991; 71:481-539.
8. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev. 1993;73:1-78.
9. Knepper PA, Covici S, Fadel JR, Mayanil CSK, Ritch R. Surface-tension properties of hyaluronic acid. J Glaucoma. 1995;4:194-199.
10. Knepper PA, Farbman AI, Tesler AG. Aqueous outflow pathway glycosaminoglycans. Exp Eye Res. 1981; 32:265-277.
11. Kaufman PL. Pressure-dependent outflow. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: CV Mosby; 1989:219-240.
12. Rohen JW. Why is intraocular pressure elevated in chronic simple glaucoma? Ophthalmology. 1983;90: 758-765.
13. Goossens W, Hvizd MG, Higbee RG, Palmberg PF, Knepper PA. GAG stratification in normal and primary open-angle glaucoma juxtacanalicular connective tissue. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1989;30:205.
14. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
15. Lutjen-Drecoll E, Futa R, Rohen JW. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1981;21:563-572.
16. Segawa K, Ultrastructural changes of trabecular tissues in primary open-angle glaucoma. Jpn J Ophthalmol. 1975;19:311-338.
17. Rodrigues, MM, Spaeth GL, Sivalingham E, Weinreb S. Histopathology of 150 trabeculectomy specimens of glaucoma. Trans Ophthalmol Soc UK. 1976;96:245-253.
18. Francois J. The importance of mucopolysaccharides in intraocular pressure regulation. Invest Ophthalmol Vis Sci. 1975;14:173-176.
19. Higbee RG, Knepper PA. The use of ethanol for preserving proteins and glycoproteins of the trabecular meshwork. J Glaucoma. 1993;2:25-29.
20. Johnson DH, Knepper PA. Microscale analysis of the GAGs of human trabecular meshwork: A study in perfused cultured eyes. J Glaucoma. 1994;3:58-69.
21. Schmid K, Wernli M, Nimberg RB. A microtechnique for the rapid determination of the glycosaminoglycans of vascular tissues. Anal Biochem. 1982;121:91-96.
22. Breen M, Knepper PA, Weinstein HG, Blacik LJ, Lewandowski DG, Baltrus BM. Microanalysis of glycosaminoglycans. Anal Biochem. 1981;113:416-422.
23. Knepper PA, Collins JA, Frederick R. Effect of dexamethasone, progesterone and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci. 1985;26:1093-1100.
24. Knepper PA, Losey RK, Collins JA, McLone DG, Weinstein HG, Breen M. Age-related changes in the cerebrospinal fluid outflow glycosaminoglycans. Neurobiol Aging. 1983;4:163-168.
25. Ohya T, Kaneko Y. Novel hyaluronidase from streptomyces. Biochem Biophys Acta. 1970;198:607-609.
26. Saito H, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem. 1975;243:1536-1542.
27. Nakazawa K, Suzuki S. Purification of keratan sulfate-endogalactosidase and its action on keratan sulfates of different origin. J Biol Chem. 1975;350:912-917.
28. Conrad GW, Hart GW. Heparan sulfate biosynthesis by embryonic tissues and primary fibroblast populations. Dev Biol. 1975;44:253-269.
29. Collins JA, Gum GG, Palmberg, PF, Knepper PA. Microscale analysis of glycosaminoglycans from single human trabecular meshwork. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1986;27:162.
30. Sames K. The role of proteogylcans and glycosaminoglycans in aging. In: von Hahn HP, ed. Interdisciplinary Topics in Gerontology. Basel: Karger; 1994;28:46-50.
31. Alavardo J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and non-glaucomatous normals. Ophthalmology. 1984;91:564-579.
32. Knepper PA, Hvizd MG, McLone DG, Higbee RG, Goossens W, Palmberg PF. GAG profile of normal and POAG lamina cribrosa. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1990;31:564.
33. Zhan GL, Miranda OC, Bito LZ. Steroid glaucoma; Corticosteroid-induced ocular hypertension in cats. Exp Eye Res. 1992;54:211-218.
34. DeSantis L, Garthwaite C, Knepper PA. Dexamethasone-induction of ocular hypertension in the primate. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1990;31:99.
35. Kass MA, Johnson T. Corticosteroid-induced glaucoma. In: Ritch R, Shields MB, Krupin, eds. The Glaucomas. St. Louis: CV Mosby; 1989:1161-1168.
36. Knepper PA, Breen M, Weinstein HG, Blacik, LJ. Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: Effect of age and dexamethasone. Exp Eye Res. 1981;32:265-277.
37. Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993;34:3386-3395.
38. Tripathi RC, Yang C, Tripathi BJ, Borisuth NSC. Role of receptors in the trabecular meshwork of the eye as targeted to the development of antiglaucoma therapy. Drug Dev Res. 1992;27:191-238.
39. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 1992;71:1065-1068.
40. Acott TS. Biochemistry of aqueous humor outflow. In: Kaufman PL, Mittag TW, eds. Textbook of Ophthalmology. Vol 7. Glaucoma. London: Mosby; 1994:1.47-1.78.
41. Laurent TC, Laurent UBG, Fraser JRE. Functions of hyaluronan. Ann Rheum Dis. 1995;54:429-432.
42. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 1993;7:1233-1241.